AOC 1020

· Avidity Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AOC 1020, covering 2024-12-20 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) [Phase 1, Phase 2]